William Blair & Company’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

William Blair & Company’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-75,535	Closed	-$1.84M	–	1638
2017 Q4	$1.84M	Sell	75,535 -56,825	-43%	-$1.09M	0.01%	587
2017 Q3	$2.44M	Buy	132,360 +36,980	+39%	+$641K	0.02%	508
2017 Q2	$1.58M	Buy	95,380 +6,330	+7%	+$88.1K	0.01%	627
2017 Q1	$1.23M	Buy	+89,050	New	+$1.43M	0.01%	655
2015 Q3	–	Sell	-8,050	Closed	-$208K	–	1615
2015 Q2	$208K	Buy	+8,050	New	+$203K	﹤0.01%	2050

William Blair & Company's ENTL Position: Q1 2018 in Review

William Blair & Company sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 75,535 shares — an estimated $1.84M sold.

William Blair & Company first reported a position in ENTL in Q2 2015 and held it in 5 quarters. The position peaked at $2.44M in Q3 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

William Blair & Company reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
William Blair & Company sold 75,535 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $1.84M.
William Blair & Company first reported a position in Entellus Medical, Inc. Common Stock in Q2 2015 and held it in 5 quarters.
William Blair & Company's Entellus Medical, Inc. Common Stock position peaked at $2.44M in Q3 2017.
0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on William Blair & Company's 13F filing for Q1 2018, filed 15 May 2018.